Jaguar Health (JAGX) Other Non-Current Assets (2015 - 2026)
Jaguar Health (JAGX) reported Other Non-Current Assets of $2.8 million for Q1 2026, up 106.83% year-over-year from $1.3 million in Q1 2025, and up 463.97% quarter-over-quarter from $494000.0 in Q4 2025.
Jaguar Health (JAGX) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Other Non-Current Assets data on file, last reported at $2.8 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $2.8 million, up 106.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (up 106.83% YoY), and the FY2025 annual result was $494000.0, down 63.35% from the prior year.
- Other Non-Current Assets rose to $2.8 million in Q1 2026 per JAGX's latest filing, from $494000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $2.8 million in Q1 2026 and troughed at $275000.0 in Q1 2024.
- A 5-year average of $1.1 million and a median of $1.0 million in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets surged 2247.37% in 2022, then plunged 72.83% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $995000.0 in 2022, then advanced by 1.71% to $1.0 million in 2023, then surged by 33.2% to $1.3 million in 2024, then plunged by 63.35% to $494000.0 in 2025, then soared by 463.97% to $2.8 million in 2026.
- Business Quant data shows JAGX's Other Non-Current Assets at $2.8 million in Q1 2026, $494000.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 494,000.00 |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 276,000.00 |
| Mar 31, 2024 | 275,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.01 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 995,000.00 |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 446,000.00 |
| Dec 31, 2021 | 446,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 37,000.00 |